Overview
Jessica Baude practices practicing medicine in Villeurbanne, France.
Her clinical expertise encompasses Necrotizing Fasciitis, Toxic Shock Syndrome, and Streptococcal Group A Infection.
She is actively involved in clinical research, co-authoring 12 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jessica Baude
Is Jessica Baude a top-rated expert for Necrotizing Fasciitis?
MediFind is an objective health platform that identifies experts based on real-world data. Jessica Baude is classified as an Experienced expert for Necrotizing Fasciitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jessica Baude participate in research or clinical trials?
Yes. Jessica Baude has published 12 articles and abstracts on conditions like Necrotizing Fasciitis. You can view a list of Jessica Baude's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Necrotizing FasciitisMs. Baude isExperienced. Learn about Necrotizing Fasciitis.
- Streptococcal Group A InfectionMs. Baude isExperienced. Learn about Streptococcal Group A Infection.
- Toxic Shock SyndromeMs. Baude isExperienced. Learn about Toxic Shock Syndrome.